- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information available. Pharmacokinetic studies in children were not conducted.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Available formulations
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dosages
| Inflammation of the outer ear |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
Aluminiumacetotartrate ear drops of 12% are only recommended when the eardrum is closed. With an open eardrum, the risk of ototoxicity is greater.
Contact with the doctor is necessary if a stinging or burning sensation persists for more than a few hours after administration.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| Antiinfectives | ||
|---|---|---|
| S02AA15 | ||
| ANTIINFECTIVES | ||
|---|---|---|
| S02AA15 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
References
- van Balen FA, et al., Clinical efficacy of three common treatments in acute otitis externa in primary care: randomized controlled trial. , BMJ, 2003, 327(7425), 1201-5
- Wiersma TJ, et al., Summary of the practice guideline 'Otitis externa' (first revision) from the Dutch College of General Practitioners., Ned Tijdschr Geneeskd., 2008, 152(21), 1210-4
- Mylanus EA, et al., Choice of ear drops in chronic otorrhea, Ned Tijdschr Geneeskd., 2000, 144(26), 1261-6
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Changes
Changes
